News

MUSC researchers have engineered a new type of genetically modified immune cell that could help organ transplant patients who are prone to rejection.

Many people remain unaware that HPV can cause six types of cancer – and that can affect whether people choose to vaccinate.

Counties with historically lower rates of screening for cervical cancer have higher rates of late-stage diagnosis and death.

An MUSC study lays the scientific groundwork for a new approach to preventing compromised kidney function and kidney failure in patients with lupus.

Details in medical record notes are often critical to proper care. AI can help highlight those notes as patients move among doctors in different specialties.

MUSC helps lead study finding nerve blocks reduce pain in kids with broken legs.

Hollings researcher Dr. Shikhar Mehrotra received two NCI grants to improve T-cells functioning against cancer.

A Hollings researcher led a group that developed an immunotherapy to target leukemia stem cells; they hope to move to clinical trials soon.

An undergrad is spending her summer studying pediatric sarcoma in the lab of Dr. Casey Langdon, thanks to a grant from the St. Baldrick's Foundation.

Researchers at MUSC Hollings Cancer Center are working to develop new drug combinations for people with treatment-resistant cancer.